Drawing for SALONPAS GEL-PATCH HOT SOOTHING

USPTO serial 78197813

SALONPAS GEL-PATCH HOT SOOTHING

Reviewed by CopyMark Law Group

Reg. 2806669Status 710
Filing date
Status date
Registration date
Jan 20, 2004
Examiner
WOOD, CAROLINE
Law office
GENERIC WEB UPDATE

What this means

Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.

Status 710: Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active.

Need help with SALONPAS GEL-PATCH HOT SOOTHING?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Scott S. Havlick

Scott S. Havlick Holland & Hart LLP555 Seventeenth Street, Suite 3200,P.O.Denver CO, CO 80201UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005Medicated transdermal patches, plasters, and pads for relief of aches of rheumatoid arthritis, and the aches and pains of muscles, joints and tendons; other pharmaceuticals in the form of patches, [ plasters, pads and cataplasms for use in the treatment of lumbago, namely, muscular and facial lumbago, spondylosis deformans discopathy, and sprain of lumbar spine, osteoarthritis, humeroscapular periarthritis, tendinitis, tendo-vaginitis, peritendinitis, humeral epicondylitis, tennis elbow, myalgia and post-traumatic swelling and pain; anti-inflammatory and analgesic agents; medical adhesive plasters; Medicated transdermal patches, plasters, and pads for relief of aches of rheumatoid arthritis, and the aches and pains of muscles, joints and tendons; other pharmaceuticals in the form of patches, plasters, pads and cataplasms for use in the treatment of lumbago, namely, fascial lumbago, spondylosis deformans discopathy, and sprain of lumbar spine, osteoarthritis, humeroscapular periarthritis, tendinitis, tendo-vaginitis, peritendinitis, humeral epicondylitis, tennis elbow, myalgia and post-traumatic swelling and pain;] anti-inflammatory and analgesic agents [; medical adhesive plasters]SECTION 8 - CANCELLEDFeb 12, 2003

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Aug 2, 2024CAEXCANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9—
Jan 20, 2023REM2COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED—
Jan 3, 2014NA89NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED—
Jan 3, 2014RNL1REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)The trademark registration was renewed for another 10-year term after acceptable maintenance filings. RNL1, RNL2, and RNL3 indicate which renewal cycle (first, second, or third 10-year term) was recorded. The registration remains active.
Jan 3, 201489AGREGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTEDThe USPTO accepted your combined Section 8 declaration and Section 9 renewal application. The registration is renewed for another 10-year term. The next combined maintenance filing will be due at the following 10-year anniversary.
Jan 3, 2014APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Dec 20, 201389AFREGISTERED - COMBINED SECTION 8 (10-YR) & SEC. 9 FILED—
Dec 20, 2013E89RTEAS SECTION 8 & 9 RECEIVED—
Sep 14, 2009C15AREGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.—
Sep 11, 2009PLGLASSIGNED TO PARALEGAL—
Sep 1, 2009E815TEAS SECTION 8 & 15 RECEIVED—
Jun 5, 2007CFITCASE FILE IN TICRS—
Sep 19, 2004COC.CORRECTION UNDER SECTION 7 - PROCESSED—
Jul 26, 2004AMD7SEC 7 REQUEST FILED—
Jan 20, 2004R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Oct 28, 2003PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Oct 8, 2003NPUBNOTICE OF PUBLICATION—
Aug 25, 2003CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Aug 25, 2003IUAAUSE AMENDMENT ACCEPTED—
Jul 17, 200344DDSEC. 44(D) CLAIM DELETED—
Jul 17, 2003CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jul 17, 2003TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jun 10, 2003GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 2, 2003DOCKASSIGNED TO EXAMINER—
Apr 22, 2003AUPCAMENDMENT TO USE PROCESSING COMPLETE—
Mar 28, 2003AMPXPRELIMINARY/VOLUNTARY AMENDMENT - ENTERED—
Mar 28, 2003IUAFUSE AMENDMENT FILED—
Mar 28, 2003CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Mar 28, 2003EAAUTEAS AMENDMENT OF USE RECEIVED—
Feb 10, 2003PARITEAS VOLUNTARY AMENDMENT RECEIVED—
Jan 16, 2003PARITEAS VOLUNTARY AMENDMENT RECEIVED—

Frequently asked questions

Related guidance